Actively Recruiting
The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy: A Prospective Observational Preliminary Study
Led by Jaseng Medical Foundation · Updated on 2026-02-25
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness and safety of Korean integrative treatments in adults aged 19 to 69 diagnosed with peripheral facial nerve palsy. This observational study focuses on patients in the acute to subacute stage of facial palsy, following their progress primarily through the Facial Disability Index (FDI) over a period of several months after starting treatment. The study is sponsored by the Jaseng Medical Foundation and aims to observe real-world clinical practices with treatments determined by experienced clinicians. Participants receive various Korean integrative medicine treatments, including Chuna therapy (a manual technique on the face and cervical spine), acupuncture, pharmacopuncture, and herbal medicine. The exact treatment plan is decided by clinicians based on each patient's condition. Treatment visits occur weekly while treatment is ongoing, with follow-up visits scheduled at the 5th, 14th, and 53rd weeks after the baseline assessment. During the study, researchers will collect data at several time points using various assessments such as the Facial Disability Index, House-Brackmann facial palsy grading, Numeric Rating Scale, Facial Nerve Grading System, Synkinesis Assessment Questionnaire, Patient Global Impression of Change, and the Short Form-12 Health Survey. These measures help track changes in facial function and patient well-being. The study will monitor participants for over a year to observe both short- and long-term outcomes related to facial palsy and treatment effects.
CONDITIONS
Brief Title
The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 19 and 69 years
- Diagnosed with unilateral peripheral facial nerve palsy
- Onset of facial palsy within the last 3 weeks
- Able to provide written consent to participate in the study
You will not qualify if you...
- Diagnosed with central nervous system disease causing facial palsy
- Secondary facial palsy after multiple sclerosis, tumor, cerebrovascular disease, or temporal bone fracture
- Ramsay-Hunt syndrome
- Bilateral or recurrent facial nerve palsy
- Received treatment affecting facial paralysis within the last 2 months (e.g., facial nerve decompression surgery)
- Pregnant, breastfeeding, or planning pregnancy during the study period
- Uncontrolled diabetes mellitus within the last 3 months
- Participated in other facial palsy-related clinical trials within the last month or planning participation within 6 months
- Unable to read or understand informed consent forms and questionnaires
- Deemed difficult to participate by researchers based on judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Ongoing during treatment period
Participants who receive Korean integrative medicine for facial palsy are observed. Treatment is determined by experienced clinicians based on individual medical conditions.
Weekly visits during treatment
Duration - Up to 53 weeks after baseline
Participants are assessed after treatment ends to monitor facial palsy recovery and safety.
Visits at weeks 5, 14, and 53
Trial Site Locations
Total: 1 location
1
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea, 135-896
Actively Recruiting
Research Team
I
In-Hyuk Ha, KMD,Ph.D
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here